Until recently, expert guidelines such as the 2005 36th Bethesda Conference Guidelines¹ and the 2005 European Society of Cardiology² guidelines have recommended disqualification from most competitive sports for athletes with a variety of genetic heart diseases, aiming to prevent sudden cardiac death. However, recent studies have shown that carefully selected athletes with a variety of genetic heart diseases, including catecholaminergic polymorphic ventricular tachycardia and long QT syndrome, who elected to continue in competitive sports after a shared decision-making evaluation rarely experienced disease-triggered breakthrough cardiac events.^3–5 These observations have prompted acknowledgment of the importance of shared decision making and consideration of an athlete’s desire to return-to-play in the recent 2015 American Heart Association/American College of Cardiology scientific statement.⁵ This document recognized that the foundational evidence to compel a recommendation for disqualification was disease-dependent and, in many instances, lacking.⁵ It updated the Bethesda guidelines by defining return-to-play as an approval from an expert who specializes in genetic heart diseases to participate in competitive sports after a thorough examination and a comprehensive treatment/management plan has been established. Additionally, the statement advised disclosure of the athlete’s medical condition to the athlete’s school/university with no guarantee that the host institution will uphold the return-to-play decision.⁵

After approval by the Mayo Clinic Institutional Review Board, a …

直到最近，专家指南（例如2005年第36届Bethesda会议指南¹和2005年欧洲心脏病学会²指南）都建议取消具有多种遗传性心脏病的运动员的大多数竞技运动资格，以防止心脏猝死。然而，最近的研究表明，精心挑选的患有多种遗传性心脏病的运动员，包括儿茶酚胺能性多形性室性心动过速和长QT综合征，他们经过共同的决策评估后选择继续参加竞技运动，很少遇到因疾病引起的突破性心脏事件。^{3 – 5}这些发现促使人们在最近的2015年美国心脏协会/美国心脏病学会的科学声明中认识到共同决策的重要性，并考虑了运动员重返比赛的愿望。⁵该文件认识到，强制取消资格推荐的基础证据取决于疾病，在许多情况下是缺乏的。⁵它对Bethesda指南进行了更新，将重返赛程定义为经过全面检查并制定了全面的治疗/管理计划后，获得遗传心脏病专科医生参加竞技运动的认可。此外，该声明还建议向运动员的学校/大学披露运动员的健康状况，但不能保证主办机构会坚持比赛的决定。⁵

经过梅奥诊所机构审查委员会的批准，…